Inspira Technologies Secures First U.S. Purchase Order for ART100 Systems
Ticker: IINNW · Form: 6-K · Filed: Jun 13, 2024 · CIK: 1837493
Sentiment: bullish
Topics: new-market-entry, purchase-order, medical-devices
TL;DR
Inspira just landed its first U.S. order for ART100 systems! Big step into the American market.
AI Summary
On June 13, 2024, Inspira Technologies Oxy B.H.N. Ltd. announced it received its first purchase order for its INSPIRA ART100 systems in the U.S. This order signifies a significant step for the company in entering the U.S. market with its innovative medical technology.
Why It Matters
This marks Inspira's initial entry into the U.S. market for its ART100 systems, potentially opening up substantial revenue streams and validating its technology in a key global healthcare market.
Risk Assessment
Risk Level: medium — While a positive development, the actual financial impact and scalability of this first U.S. order are yet to be determined, and market adoption remains a key factor.
Key Players & Entities
- Inspira Technologies Oxy B.H.N. Ltd. (company) — Registrant
- INSPIRA ART100 (product) — System for which purchase order was received
FAQ
What is the significance of this purchase order for Inspira Technologies?
This is the first purchase order for Inspira's INSPIRA ART100 systems in the U.S., marking the company's entry into the U.S. market.
When was this announcement made?
The announcement was made on June 13, 2024.
What specific product is involved in this purchase order?
The purchase order is for the INSPIRA ART100 systems.
What type of filing is this report?
This is a Form 6-K, Report of Foreign Private Issuer.
Where is Inspira Technologies Oxy B.H.N. Ltd. based?
The company's principal executive office is located at 2 Ha-Tidhar St. Ra'anana, Israel.
Filing Stats: 295 words · 1 min read · ~1 pages · Grade level 8.2 · Accepted 2024-06-13 09:30:11
Filing Documents
- ea0207815-6k_inspira.htm (6-K) — 11KB
- ea020781501ex99-1_inspira.htm (EX-99.1) — 9KB
- 0001213900-24-052263.txt ( ) — 21KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Inspira Technologies Oxy B.H.N. Ltd. Date: June 13, 2024 By: /s/ Dagi Ben-Noon Name: Dagi Ben-Noon Title: Chief Executive Officer 2